Hypertriglyceridemia clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
open to eligible people ages 18 years and up
The purpose of this study is to evaluate the safety and tolerability of olezarsen in participants with SHTG.
at UCSD